We are live on ! Find out more
JC

JBF Capital Portfolio holdings

AUM $764M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$633M
AUM Growth
-$163M
Cap. Flow
-$170M
Cap. Flow %
-26.82%
Top 10 Hldgs %
87.77%
Holding
108
New
44
Increased
9
Reduced
4
Closed
26

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$6.93M
2
GE icon
GE Aerospace
GE
+$6.18M
3
ACTA
Actua Corp
ACTA
+$5.71M
4
KRNY icon
Kearny Financial
KRNY
+$4.73M
5
CHRD icon
Chord Energy
CHRD
+$4.49M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$223M
2
SRUN
Silver Run Acquisition Corporation II Class A
SRUN
+$9.46M
3
AABA
Altaba Inc
AABA
+$4.19M
4
QIWI
QIWI PLC
QIWI
+$869K
5
HTM
U.S. Geothermal Inc.
HTM
+$236K

Sector Composition

Rank Sector Weight
1 Financials 6.68%
2 Technology 4.79%
3 Consumer Discretionary 3.24%
4 Healthcare 2.75%
5 Energy 1.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
26
PUT
Apple
AAPL
$4.46T
$1.58M 0.25%
+4,000
New +$172K
RCUS icon
27
Arcus Biosciences
RCUS
$3.67B
$1.54M 0.24%
+100,000
New +$1.67M
ESTE
28
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$1.52M 0.24%
150,610
– –
MTEX icon
29
Mannatech
MTEX
$11.9M
$1.28M 0.2%
81,286
+41,668
+105% +$612K
RDI icon
30
Reading International Class A
RDI
$33.2M
$1.24M 0.2%
74,325
+35,899
+93% +$596K
GCAP
31
DELISTED
Gain Capital Holdings, Inc.
GCAP
$1.19M 0.19%
176,800
+80,000
+83% +$600K
AMRWW
32
CALL
DELISTED
Alta Mesa Resources Inc Warrant
AMRWW
$1.15M 0.18%
+740,832
New +$1.28M
TSLA icon
33
CALL
Tesla
TSLA
$1.34T
$1.11M 0.18%
+4,170
New +$91.7K
CPRX
34
DELISTED
Catalyst Pharmaceutical
CPRX
$1.1M 0.17%
+458,600
New +$1.52M
FSACU
35
DELISTED
Federal Street Acquisition Corp. Unit
FSACU
$1.02M 0.16%
100,000
– –
BMRN icon
36
BioMarin Pharmaceuticals
BMRN
$13.3B
$1.02M 0.16%
+12,560
New +$1.08M
BPMC
37
DELISTED
Blueprint Medicines
BPMC
$992K 0.16%
+10,822
New +$933K
BXC icon
38
BlueLinx
BXC
$705M
$909K 0.14%
27,900
-3,900
-12% -$72.5K
EIRL icon
39
iShares MSCI Ireland ETF
EIRL
$78.8M
$907K 0.14%
19,411
– –
MR
40
DELISTED
Montage Resources Corporation Common Stock
MR
$882K 0.14%
+40,825
New +$1.17M
AMZN icon
41
PUT
Amazon
AMZN
$2.86T
$865K 0.14%
+4,000
New +$286K
JNCE
42
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$852K 0.13%
+38,100
New +$846K
XLNX
43
CALL
DELISTED
Xilinx Inc
XLNX
$840K 0.13%
1,000
– –
IRL
44
DELISTED
NEW IRELAND FUND INC
IRL
$724K 0.11%
60,100
– –
DIS icon
45
Walt Disney
DIS
$181B
$713K 0.11%
+7,100
New +$754K
CTMX icon
46
CytomX Therapeutics
CTMX
$730M
$692K 0.11%
+24,333
New +$695K
GNW icon
47
Genworth Financial
GNW
$3.77B
$688K 0.11%
+242,964
New +$730K
BMY icon
48
Bristol-Myers Squibb
BMY
$132B
$670K 0.11%
+10,600
New +$682K
CET
49
Central Securities Corp
CET
$1.63B
$667K 0.11%
25,000
– –
BOLD
50
DELISTED
Audentes Therapeutics, Inc
BOLD
$640K 0.1%
+21,300
New +$721K
1
2
3 4 5

Similar funds

CCIP
Camrose Capital Investment Partners London, United Kingdom $764M AUM 0.9% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
GWM
Gibbs Wealth Management Alpharetta, Georgia $762M AUM 18.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
PGA
Pilgrim Global Advisors Reno, Nevada $772M AUM 51.79% 1-Year Est. Return

JBF Capital's Q1 2018 Portfolio in Review

As of Q1 2018, JBF Capital held 108 positions worth $633M, down 20% from $795M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

JBF Capital withdrew a net $170M in Q1 2018, closing 26 positions and reducing 4 holdings. Its most notable exit was Silver Run Acquisition Corporation II Class A, an estimated $9.46M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, up from 5.4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, JBF Capital opened a new position in Alexion Pharmaceuticals worth $6.46M.

  • JBF Capital's largest Q1 2018 buy was Alexion Pharmaceuticals: 58,000 shares worth $6.46M.
  • JBF Capital added most to Chord Energy in Q1 2018, an estimated $4.49M increase.
  • JBF Capital's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • JBF Capital fully exited Silver Run Acquisition Corporation II Class A in Q1 2018, selling an estimated $9.46M.
  • JBF Capital's ten largest holdings make up 88% of its $633M portfolio in Q1 2018.
  • JBF Capital opened 44 new positions and closed 26 in Q1 2018.
  • JBF Capital's portfolio value fell 20% quarter-over-quarter to $633M.

Based on JBF Capital's 13F filing for Q1 2018, filed 11 May 2018.